Search

You searched for "lesion"

2379 results found

Just sign here: the intricacies of consent in the post-Montgomery era

1 February 2018 | EYE - General
The consent process is a vital part of the patient pathway and is far more than just getting the patient to sign on the dotted line. In my work in litigation I often see issues around informed consent resulting in...

The results of the last survey Dec24

4 December 2024 | | EYE - Glaucoma, EYE - Vitreo-Retinal, EYE - Cataract
This edition’s survey results are fascinating. They focus more on your impressions and views rather than on the facts of your clinical practice. Effectively I asked you to take the role of an expert and comment on the cases I...

The results of the last survey Feb25

4 February 2025 | | EYE - Glaucoma, EYE - Vitreo-Retinal, EYE - Cataract
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. The sample...

Patients blinded by stem cells! How safe are they really?

1 October 2018 | | EYE - Vitreo-Retinal, EYE - General
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Patients blinded by stem cells! How safe are they really? Ever since the successful results following...

Dramatic myopic shift due to epithelial basement membrane dystrophy

3 October 2024 | | EYE - Cornea
Epithelial basement membrane dystrophy (EBMD), also known as map-dot-fingerprint dystrophy, is a common anterior corneal disorder affecting approximately 2% of the population [1]. It is characterised by the abnormal maintenance of the basement membrane, resulting in protrusions into the epithelium....

Cataract incidence rates in patients from the UK suffering with diabetes mellitus

1 October 2018 | | EYE - Cataract, EYE - Refractive, EYE - General
The authors summarise the main findings from a recent study which investigated the incidence rates of cataract in patients with or without diabetes mellitus (DM). Background to the study Worldwide, the World Health Organization (WHO) estimates that 253 million people...

Decoding the red eye

15 February 2021 | | EYE - Cornea
Red eye, or hyperaemia, is one of the most common presentations to primary care [1] and the emergency department [2]. However, despite this the underlying cause is often misdiagnosed which can lead to severe, sight-threatening conditions being missed [1]. Thorough...

When science meets art: Creating brilliant sparks

4 February 2025 | | EYE - Glaucoma
I was honoured to have the privilege of reconnecting with the Tongren Eye Center team in Beijing, China. Digital art in mainstream media has showcased some glorious works and it is humbling to see and hear about some creative new...

Working smarter not harder: How to transform eyecare delivery in the United Kingdom (part 1)

1 December 2021 | | EYE - General
Are we doing enough to meet the current demands on ophthalmic services? In part one of a two-part series (see Part 2 here), Rosalind Harrison takes a look at how efficiency has been improved in eyecare services in the US....

Fight for Sight and The Royal College of Ophthalmologists invite applications for John Lee Primer Fellowships for research into sight loss

7 October 2019
In partnership with The Royal College of Ophthalmologists, Fight for Sight is now inviting applications for its John Lee Primer Fellowships, offering up to £60,000 to support early career ophthalmologists to undertake ground-breaking vision research.

New national programme of sight tests in special schools

12 February 2020
As a result of SeeAbility’s campaigning, NHS England are planning for a new national programme of sight tests and glasses dispensing in England’s special schools from 2020. SeeAbility’s model of sight testing is less stressful for children with learning disabilities...

Optical practices to stop providing routine sight tests

24 March 2020
The following is a joint statement from the Optometric Fees Negotiating Committee (OFNC), Optometry Scotland, Optometry Wales and Optometry Northern Ireland.